Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture

被引:105
作者
Lupu, C [1 ]
Poulsen, E [1 ]
Roquefeuil, S [1 ]
Westmuckett, AD [1 ]
Kakkar, VV [1 ]
Lupu, F [1 ]
机构
[1] Thrombosis Res Inst, Weston Ctr Expt Res, Vasc Biol Lab, London SW3 6LR, England
关键词
tissue factor pathway inhibitor; human endothelial cells; unfractionated heparin; low-molecular-weight heparin; caveolae;
D O I
10.1161/01.ATV.19.9.2251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue factor pathway inhibitor (TFPI), the major downregulator of procoagulant activity of the tissue factor-factor VIIa complex (TF . FVIIa), is synthesized and constitutively secreted by endothelial cells (ECs). Here we describe the in vitro effects of heparin on the cellular localization, gene expression, and release of TFPI in human ECs in culture. Both unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH; Fragmin) time-dependently induced a significant enhanced secretion of TFPI, paralleled by a redistribution and increase of TFPI on the cell surface and a decrease of intracellular TFPI. Immunogold electron microscopy showed the presence of clusters of TFPI, both on the plasmalemma proper and within cell-surface opened caveolae/enlarged caveolar profiles. Activation of FX by TF FVIIa on ECs treated with endotoxin was inhibited by both heparins but to a higher extent by LMWH, Inhibition of protein synthesis by cycloheximide did not reduce the release of TFPI induced by heparin. Long-term incubation (48 hours) resulted in a time-dependent enhanced production of TFPI. After the first 4 to 8 hours, depletion of intracellular TFPI was observed, more significantly with UFH. Northern blot analysis of TFPI mRNA also showed a decrease of the 1.4-kb transcript after 4 hours of incubation with UFH, followed by recovery and an increase over the control level after 24 hours. Incubation of ECs with phorbol ester (PMA) significantly enhanced the secretion of TFPI and increased its activity on the cell surface, probably by preventing invagination of caveolae, Heparin-stimulated release of TFPI decreased significantly in the presence of PMA to a level that was 2.4 times lower than the expected additive value for PMA and UFH separately. Pretreatment of ECs with PMA suppressed a subsequent response to heparin. Altogether, our results suggest that the heparin-induced release of TFPI might involve a more specific mechanism(s) than the previously hypothesized simple displacement of TFPI from the cell surface glycocalyx, We assume that the increased secretion and redistribution of cellular TFPI induced by heparins in ECs in culture can play an important role in the modulation of the anticoagulant properties of the endothelium.
引用
收藏
页码:2251 / 2262
页数:12
相关论文
共 57 条
[21]   Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice [J].
Huang, ZF ;
Higuchi, D ;
Lasky, N ;
Broze, GJ .
BLOOD, 1997, 90 (03) :944-951
[22]   CONTINUOUS INTRAVENOUS HEPARIN COMPARED WITH INTERMITTENT SUBCUTANEOUS HEPARIN IN THE INITIAL TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J].
HULL, RD ;
RASKOB, GE ;
HIRSH, J ;
JAY, RM ;
LECLERC, JR ;
GEERTS, WH ;
ROSENBLOOM, D ;
SACKETT, DL ;
ANDERSON, C ;
HARRISON, L ;
GENT, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (18) :1109-1114
[23]   Binding of tissue factor pathway inhibitor to cultured endothelial cells - Influence of glycosaminoglycans [J].
Iverson, N ;
Sandset, PM ;
Abildgaard, U ;
Torjesen, PA .
THROMBOSIS RESEARCH, 1996, 84 (04) :267-278
[24]   Initiation of the tissue factor pathway of coagulation in the presence of heparin: Control by antithrombin III and tissue factor pathway inhibitor [J].
Jesty, J ;
Lorenz, A ;
Rodriguez, J ;
Wun, TC .
BLOOD, 1996, 87 (06) :2301-2307
[25]  
KUMAR A, 1994, THROMB HAEMOSTASIS, V71, P587
[26]   ELECTROBLOTTING OF MULTIPLE GELS - A SIMPLE APPARATUS WITHOUT BUFFER TANK FOR RAPID TRANSFER OF PROTEINS FROM POLYACRYLAMIDE TO NITROCELLULOSE [J].
KYHSEANDERSEN, J .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1984, 10 (3-4) :203-209
[27]   ANTICOAGULANT ACTIVITY OF TISSUE FACTOR PATHWAY INHIBITOR IN HUMAN PLASMA IS PREFERENTIALLY ASSOCIATED WITH DENSE SUBSPECIES OF LDL AND HDL AND WITH LP(A) [J].
LESNIK, P ;
VONICA, A ;
GUERIN, M ;
MOREAU, M ;
CHAPMAN, MJ .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (07) :1066-1075
[28]  
LEVIN EG, 1989, J BIOL CHEM, V264, P16030
[29]   TISSUE FACTOR PATHWAY INHIBITOR WITH HIGH ANTICOAGULANT ACTIVITY IS INCREASED IN POSTHEPARIN PLASMA AND IN PLASMA FROM CANCER-PATIENTS [J].
LINDAHL, AK ;
JACOBSEN, PB ;
SANDSET, PM ;
ABILDGAARD, U .
BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (06) :713-721
[30]   THE PRESENT STATUS OF TISSUE FACTOR PATHWAY INHIBITOR [J].
LINDAHL, AK ;
SANDSET, PM ;
ABILDGAARD, U .
BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (04) :439-449